M&A Deal Summary

HeartWare International Acquires World Heart

On March 29, 2012, HeartWare International acquired medical products company World Heart for 8M USD

Acquisition Highlights
  • This is HeartWare International’s 1st transaction in the Medical Products sector.
  • This is HeartWare International’s 2nd largest (disclosed) transaction.
  • This is HeartWare International’s 1st transaction in the United States.
  • This is HeartWare International’s 1st transaction in Utah.

M&A Deal Summary
Date 2012-03-29
Target World Heart
Sector Medical Products
Buyer(s) HeartWare International
Deal Type Add-on Acquisition
Deal Value 8M USD

Target

World Heart

Salt Lake City, Utah, United States
WorldHeart is a developer of mechanical circulatory support systems based in Salt Lake City, Utah.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

HeartWare International

Framingham, Massachusetts, United States
Category Company
Sector Medical Products
Employees625
Revenue 262M USD (2016)
DESCRIPTION

HeartWare International, Inc. develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat patients around the world suffering from advanced heart failure. Dedicated to developing new, minimally invasive technologies to revolutionize the treatment of patients with end-stage heart failure, HeartWare has multiple technologies in development to offer progressively less-invasive mechanical circulatory support options. HeartWare's corporate headquarters are located in Framingham, Massachusetts, and the company has technology, operations, manufacturing and distribution centers in Miami Lakes, Florida; Arden Hills, Minnesota; and Hannover, Germany.

DEAL STATS #
Overall 1 of 3
Sector (Medical Products) 1 of 3
Type (Add-on Acquisition) 1 of 3
State (Utah) 1 of 1
Country (United States) 1 of 2
Year (2012) 1 of 1
Size (of disclosed) 2 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-01 CircuLite

Teaneck, New Jersey, United States

CircuLite is a privately held, medical device company developing a unique superficially placed circulatory assist device for the treatment of chronic heart failure.

Buy $30M
Mergr

Product

Company

Legal